Medmindre fortsat ACE- hæmmer - / AIIRA- terapi skønnes nødvendig, skal patienter, der planlægger graviditet, skifte til alternativ antihypertensiv behandling med bedre sikkerhedsprofiler for brug under graviditet.
Unless continued ACE inhibitor/ AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti- hypertensive treatments which have an established safety profile for use in pregnancy.